Picture of Holly Mansell

Holly Mansell Associate Professor

E3208 Health Sciences


Dr. Mansell joined the College of Pharmacy and Nutrition in February 2013. She maintains a practice site at the Saskatchewan Transplant Program in Saskatoon as a clinical pharmacist, working with an interdisciplinary team. She teaches undergraduate pharmacy students in the area of pharmacotherapeutics. 


Dr. Mansell’s research areas of interest include solid organ transplantation, adverse effects of immunosuppression, medication adherence, patient education and interprofessional education. She is currently leading a project to improve education before kidney transplantation, and investigate the impact on post-transplant adherence.

Recent Publications

J.J. Harrison, H. Mansell, T. Blydt-Hansen. Adverse Symptoms of Immunosuppressants: A Survey of Canadian Transplant Clinicians. Clinical Transplantation. 2017; (In press)

K. Mansell, H. Mansell, W. Neubeker, H. Drake. Students’ Perceptions of and Amount of Diabetes Education in Canadian Schools of Pharmacy. Currents in Pharmacy Teaching and Learning. 2017; DOI: 10.1016/j.cptl.2017.02.003

N. Rosaasen, J, Taylor, D. Blackburn, R. Mainra, A. Shoker, *H. Mansell. 2017. Development and Validation of the K-TUT (Kidney Transplant Understanding Tool). Transplantation Direct. 2017; DOI: 10.1097/TXD.0000000000000647 

N. Rosaasen, R. Mainra, A. Shoker, J.Wilson, D.Blackburn, *H. Mansell. Education before kidney transplant: What do patients need to know? Progress in Transplantation. 2017; DOI: 10.1177/1526924816685862.

S. Del Bigio, S. Mulhall, Y. Shevchuk, *H. Mansell. Perceptions of teamwork and interprofessional education in undergraduate pharmacy students. Pharmacy Education. 2016; 16 (1) 199-209.

J. Jones, N. Rosaasen, J. Taylor, R. Mainra, A. Shoker, D. Blackburn, J. Wilson, *H. Mansell. Health Literacy, Knowledge, and Patient Satisfaction Before Kidney Transplantation. Transplant Proceedings. 2016; 48(8): 2608-2614.

A.J. Havlicek, *H. Mansell. The Community Pharmacist’s Role in Cancer Screening and Prevention. Canadian Pharmacist’s Journal. 2016; 149(5): 274-282. Review.

P. Trivedi, N. Rosaasen, *H. Mansell. Education Before Kidney Transplantation: The Health Care Provider’s Perspective. Progress in Transplantation. 2016; 26 (4); 322-327.

H. Elmoselhi, H. Mansell, M. Soliman, A. Shoker. Circulating chemokine ligand levels before and after successful kidney transplantation. Journal of Inflammation. 2016; 26;13:32.

J. Kerry, H. Mansell, H. Elmoselhi, A. Shoker. Interaction of serum phosphate with age as predictors of cardiovascular risk scores in stable renal transplant recipients. International Journal of Angiology. 2016; DOI: 10.1055/s-0036-1593827

H. Mansell, M. Soliman, H. Elmoselhi, A. Shoker. Elevated Circulating Interleukin 33 Levels in Stable Renal Transplant Recipients at High Risk for Cardiovascular Events. PLoS ONE. 2015; 10(11): e0142141. doi:10.1371/journal.pone.0142141.

J. Stroeder, C. Evans, *H. Mansell. Corticosteroid-Induced Bradycardia: Case report and review of the literature. Canadian Pharmacists Journal. 2015; 148(5): 235-240.

B. Bosch, *H. Mansell.  Interprofessional collaboration in healthcare: Lessons to be learned from competitive sports. Canadian Pharmacists Journal. 2015; 148(4): 176-179.

H. Mansell, Elmoselhi H, Shoker A. Association between circulating thrombopoietin level and cardiovascular risk prediction scores in renal transplant recipients. American Journal of Nephrology 2015; 41:147-55.

M. Benguzzi , H. Mansell, A. Hassan, H. Elmoselhi, R. Mainra, A. Shoker. Contribution of impaired renal function to cardiovascular risk prediction models in renal transplant recipients. Clinical Transplantation. 2014; 12: 1383-92.

H. Mansell. Point and Counter Point. Should hospital pharmacist’s prescribe? “Pro side”. Canadian Journal of Hospital Pharmacy. 2014; 67(5): 390-392.

H. Mansell, S. Stewart, A. Shoker. Validity of cardiovascular risk prediction models in kidney transplant recipients.  The Scientific World Journal. 2014; Article ID 750579. doi:10.1155/2014/750579.

H. Mansell, N. Rosaasen, J. Dean and A. Shoker. Evidence of enhanced systemic inflammation in stable kidney transplant recipients with low framingham risk scores. Clinical Transplantation. 2013; 27(4): E391-9. 

H. Mansell, L. Worobetz, T. Sylwestrowicz and A. Shoker. A retrospective study of framingham cardiovascular risk scores in a liver transplant population. Transplant Proceedings. 2013; 45(1): 308-314.

H. Mansell and G.J. Pearson.  Macrolide antibiotics and calcineurin inhibitors: Avoiding a far too common drug interaction in transplant patients. Canadian Pharmacists Journal. 2009; 142(2): 68-70.